Get the Full Story, Without the Noise.
Published loading...Updated

Dexcom CEO says CGMs fit MAHA agenda ‘very nicely’; Tandem preps for new products

Summary by medtechdive.com
In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

medtechdive.com broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)